# Atlantic Bridge University Fund

> Atlantic Bridge University Fund is a VC fund backing Health Care. See 33 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dublin, Ireland
- Total investments: 33
- Last investment: Aug 2025
- Lead investor: 55%
- Last updated: Aug 2026
- Website: http://www.universitybridgefund.com

Atlantic Bridge University Fund is a VC fund in Dublin focused on Health Care and Medical Device. Atlantic Bridge University Fund invest in entrepreneurs with the ambition to create world-class companies of scale. A €60m investment fund to accelerate the commercialisation of ground-breaking research and the scaling of global businesses.

## Contacts

5 contacts available for Atlantic Bridge University Fund. Shizune tracks 1 team members at Atlantic Bridge University Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/atlantic-bridge-university-fund?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $823k–$3.9M |
| Series A | $3.1M–$34M |
| Series B | $16M–$80M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 15% |
| Medical Device | 5 | 15% |
| Big Data | 3 | 9% |
| Software | 2 | 6% |
| Biotechnology | 2 | 6% |

41 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 15 | 45% |
| Series A | 7 | 21% |
| Series B | 2 | 6% |
| Funding Round | 1 | 3% |
| Venture - Series Unknown | 1 | 3% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Ireland | 17 | 52% |
| United States | 1 | 3% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Brian Long | Founder & Managing Partner | 19 | https://shizune.co/investors/profile/brian-long-4 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ProVerum Medical | ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $80M | Series B | Aug 25, 2025 |  |
| CroíValve | CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $16M | Series B | Aug 07, 2024 |  |
| PlasmaBound | PlasmaBound provides a step-change technology, termed Controlled Plasma Ablation (CPA), which facilitates the structural adhesive joining of lightweight materials, namely carbon and glass fibre reinforced composites. CPA technology will accelerate the use of these lightweight composite materials into multi-material structural assemblies, byenabling reliable adhesive joining which is stronger than the composite structures themselves. | $2.5M | Venture - Series Unknown | May 01, 2022 |  |
| CroíValve | CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation | $9.2M | Series A | Feb 04, 2022 |  |
| ProVerum Medical | ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. |  | Series A | Jan 11, 2022 |  |
| ProVerum Medical | ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $34.1M | Series A | Jan 11, 2022 |  |
| Tympany Medical | Tympany is a platform for performing minimally invasive ear surgeries, reducing unnecessary mastoidectomys and improving outcomes. | $3.9M | Seed | Nov 22, 2021 |  |
| LUMA Vision | OneProjects is an Irish-German cardiac imaging specialist. | $8M | Series A | Oct 14, 2021 |  |
| TerminusDB | TerminusDB is an open-source full-featured in-memory graph database management system with a rich query language, WOQL.TerminusDB allows for the whole suite of revision control features: branch, merge, squash, rollback, blame, and time-travel. It is about taking data seriously, structuring data to meet business needs, and reducing the coderequired to display, distribute and manipulate data and support great decision making.TerminusDB was previously known as DataChemist, was founded in Dublin, Ireland. | $4.3M | Seed | Mar 15, 2021 |  |
| Parvalis Therapeutics | Parvalis Therapeutics develops novel autoimmune therapies for inflammatory diseases and cancer. Founded in 2020, the company is based in Dublin, Ireland. |  | Seed | Jan 01, 2021 |  |

10 of 33 investments shown.

## Co-investors
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund, 21 deals together
- [Elkstone Capital Partners](https://shizune.co/investors/profile/elkstone-capital-partners) — VC Fund, 6 deals together
- [Irrus Investments](https://shizune.co/investors/profile/irrus-investments) — VC Fund, 5 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 5 deals together
- [Ascentifi](https://shizune.co/investors/profile/ascentifi) — VC Fund, 4 deals together
- [HBAN](https://shizune.co/investors/profile/halo-business-angel-network) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund
- [NDRC](https://shizune.co/investors/profile/ndrc) — VC Fund
- [Act Venture Capital](https://shizune.co/investors/profile/act-venture-capital) — VC Fund

## Featured in investor lists
- [All Investors in Ireland](https://shizune.co/investors/investors-ireland)
- [All VC Funds in Ireland](https://shizune.co/investors/vc-funds-ireland)
- [Transportation VC Funds in Ireland](https://shizune.co/investors/transportation-vc-funds-ireland)
- [Health Care Investors in Ireland](https://shizune.co/investors/health-care-investors-ireland)
- [Health Care VC Funds in Ireland](https://shizune.co/investors/health-care-vc-funds-ireland)
- [Medical Device Investors in Ireland](https://shizune.co/investors/medical-device-investors-ireland)

## FAQ

### What does Atlantic Bridge University Fund invest in?

Atlantic Bridge University Fund invests primarily in Health Care, Medical Device and Big Data startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Atlantic Bridge University Fund's check size?

Atlantic Bridge University Fund typically joins rounds of $823k–$3.9M at Seed, $3.1M–$34M at Series A and $16M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Atlantic Bridge University Fund participates in.

### How do I contact Atlantic Bridge University Fund?

Public channels for Atlantic Bridge University Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Atlantic Bridge University Fund?

The team at Atlantic Bridge University Fund includes Brian Long (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co